Sign in
4

Changes in Ownership

Pyxis Oncology, Inc. Filed Acc 0001209191-23-047384

Options or other derivatives

  • Director acquired 26,663 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Dupont Jakob Director 2023-08-23 Grant or award · Stock Option (Right to buy) +5,879 5,879 D
Dupont Jakob Director 2023-08-23 Grant or award · Stock Option (Right to buy) +3,534 3,534 D
Dupont Jakob Director 2023-08-23 Grant or award · Stock Option (Right to buy) +17,250 17,250 D
Loading xslF345X05/doc4.xml…